【分　 类】 医药卫生
【关 键 词】 癌症，肝脏，微环境，肝细胞癌
【来 　源】 互联网
【收　 录】 中文学术期刊网

正文：

30. Chen KJ, Lin SZ, Zhou L, Xie HY, Zhou WH, et al. (2011) Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis. PLoS One 6: e24671.
31. Pedoeem A, Azoulay-Alfaguter I, Strazza M, Silverman GJ, Mor A (2014) Programmed death-1 pathway in cancer and autoimmunity. Clin Immunol 153: 145-152.
32. Fattovich G, Stroffolini T, Zagni I, Donato F (2004) Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 127: S35-50.
33. Deng YR, Yoshida K, Jin QL, Murata M, Yamaguchi T, et al. (2014) Reversible phospho-Smad3 signalling between tumour suppression and fibrocarcinogenesis in chronic hepatitis B infection. Clin Exp Immunol 176: 102-111.
34. Fang L, Huang C, Meng X, Wu B, Ma T, et al. (2014) TGF-beta1-elevated TRPM7 channel regulates collagen expression in hepatic stellate cells via TGF-beta1/Smad pathway. Toxicol Appl Pharmacol.
35. Choi SH, Chung AR, Kang W, Park JY, Lee MS, et al. (2014) Silencing of Hypoxia-Inducible Factor-1beta Induces Anti-Tumor Effects in Hepatoma Cell Lines under Tumor Hypoxia. PLoS One 9: e103304.
36. Ikeda E, Achen MG, Breier G, Risau W (1995) Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J Biol Chem 270: 19761-19766.
37. Yu DC, Chen J, Ding YT (2010) Hypoxic and highly angiogenic non-tumor tissues surrounding hepatocellular carcinoma: the 'niche' of endothelial progenitor cells. Int J Mol Sci 11: 2901-2909.
38. Goh BJ, Tan BT, Hon WM, Lee KH, Khoo HE (2006) Nitric oxide synthase and heme oxygenase expressions in human liver cirrhosis. World J Gastroenterol 12: 588-594.
39. Gao Q, Wang XY, Qiu SJ, Zhou J, Shi YH, et al. (2011) Tumor stroma reaction-related gene signature predicts clinical outcome in human hepatocellular carcinoma. Cancer Sci 102: 1522-1531.
40. van Zijl F, Mair M, Csiszar A, Schneller D, Zulehner G, et al. (2009) Hepatic tumor-stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge. Oncogene 28: 4022-4033.
41. Zhao XL, Sun T, Che N, Sun D, Zhao N, et al. (2011) Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1. J Cell Mol Med 15: 691-700.
42. Calabro SR, Maczurek AE, Morgan AJ, Tu T, Wen VW, et al. (2014) Hepatocyte Produced Matrix Metalloproteinases Are Regulated by CD147 in Liver Fibrogenesis. PLoS One 9: e90571.
43. Kim JY, Kim WJ, Kim H, Suk K, Lee WH (2009) The Stimulation of CD147 Induces MMP-9 Expression through ERK and NF-kappaB in Macrophages: Implication for Atherosclerosis. Immune Netw 9: 90-97.
44. Jiang YF, Yang ZH, Hu JQ (2000) Recurrence or metastasis of HCC:predictors, early detection and experimental antiangiogenic therapy. World J Gastroenterol 6: 61-65.
45. Ke X, Li L, Dong HL, Chen ZN (2012) Acquisition of anoikis resistance through CD147 upregulation: A new mechanism underlying metastasis of hepatocellular carcinoma cells. Oncol Lett 3: 1249-1254.
46. Chan IS, Guy CD, Chen Y, Lu J, Swiderska-Syn M, et al. (2012) Paracrine Hedgehog signaling drives metabolic changes in hepatocellular carcinoma. Cancer Res 72: 6344-6350.
47. Sicklick JK, Li YX, Melhem A, Schmelzer E, Zdanowicz M, et al. (2006) Hedgehog signaling maintains resident hepatic progenitors throughout life. Am J Physiol Gastrointest Liver Physiol 290: G859-870.
48. Mokkapati S, Niopek K, Huang L, Cunniff KJ, Ruteshouser EC, et al. (2014) beta-Catenin Activation in a Novel Liver Progenitor Cell Type Is Sufficient to Cause Hepatocellular Carcinoma and Hepatoblastoma. Cancer Res 74: 4515-4525.
49. Leonardi GC, Candido S, Cervello M, Nicolosi D, Raiti F, et al. (2012) The tumor microenvironment in hepatocellular carcinoma (review). Int J Oncol 40: 1733-1747.
50. Besaratinia A, Kim SI, Hainaut P, Pfeifer GP (2009) In vitro recapitulating of TP53 mutagenesis in hepatocellular carcinoma associated with dietary aflatoxin B1 exposure. Gastroenterology 137: 1127-1137, 1137 e1121-1125.
51. Shirabe K, Toshima T, Taketomi A, Taguchi K, Yoshizumi T, et al. (2011) Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan. Liver Int 31: 1366-1372.
52. Gursoy-Yuzugullu O, Yuzugullu H, Yilmaz M, Ozturk M (2011) Aflatoxin genotoxicity is associated with a defective DNA damage response bypassing p53 activation. Liver Int 31: 561-571.
53. Kundu D, Roy A, Mandal T, Bandyopadhyay U, Ghosh E, et al. (2012) Oxidative stress in alcoholic and viral hepatitis. N Am J Med Sci 4: 412-415.
54. Tarocchi M, Polvani S, Marroncini G, Galli A (2014) Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis. World J Gastroenterol 20: 11630-11640.
55. Su H, Zhao J, Xiong Y, Xu T, Zhou F, et al. (2008) Large-scale analysis of the genetic and epigenetic alterations in hepatocellular carcinoma from Southeast China. Mutat Res 641: 27-35.
56. Tischoff I, Tannapfe A (2008) DNA methylation in hepatocellular carcinoma. World J Gastroenterol 14: 1741-1748.
 

 

 3/3   首页 上一页 1 2 3